
    
      This non-interventional, long-term observational cohort study will evaluate demographic,
      clinical, biochemical and virological parameters of outpatients with chronic Hepatitis B who
      are under oral antiviral treatment with an approved Nucleos(t)ide for > 6 months at study
      inclusion.

      During their routine outpatient visits annually an assessment of their kidney function
      especially for a proximal tubular dysfunction will be performed and their comedication will
      be explored. Patients included in the study are followed up for 5 years.
    
  